Urology & surgical outcomes
Clinical and population-level questions in urological disease, risk stratification, and evidence that can inform surgical decision-making.
I study surgical and metabolic disease through population-level evidence and translational questions. My work connects clinical epidemiology with mechanistic research, with interests spanning urology, metabolic dysfunction-associated steatotic liver disease, liver transplantation, and ischemia–reperfusion injury.
My research brings together clinical questions, population data, and experimental mechanisms across surgical and metabolic disease.
Clinical and population-level questions in urological disease, risk stratification, and evidence that can inform surgical decision-making.
Metabolic risk markers, disease identification, and longitudinal outcomes related to MASLD and cardiometabolic health.
Graft injury, inflammatory amplification, and potential strategies to improve outcomes after liver transplantation.
How metabolic signals may shape innate immune responses and chromatin states during sterile inflammation and tissue injury.
Observational research using population cohorts, robust statistical methods, and clinically interpretable risk assessment.
Working with large cohort and national survey datasets to examine disease patterns, risk factors, and long-term outcomes.
Selected peer-reviewed publications. Visit the publication page for the full list.
For further details, see the education profile ↗.
For academic discussion, research collaboration, or questions about my work.